Michihiro Tsuchiya
Director/Board Member bij SUMITOMO ELECTRIC INDUSTRIES, LTD.
Profiel
Michihiro Tsuchiya is lid van de raad van bestuur van Sumitomo Electric Industries Ltd. en RaQualia Pharma, Inc. In het verleden bekleedde hij de functie van voorzitter van Mitsubishi Tanabe Pharma Corp. Hij is gepromoveerd aan de universiteit van Kyoto.
Actieve functies van Michihiro Tsuchiya
| Bedrijven | Functie | Begin |
|---|---|---|
| SUMITOMO ELECTRIC INDUSTRIES, LTD. | Director/Board Member | 01-06-2018 |
| RAQUALIA PHARMA INC. | Director/Board Member | 26-03-2020 |
Eerdere bekende functies van Michihiro Tsuchiya
| Bedrijven | Functie | Einde |
|---|---|---|
| MITSUBISHI CHEMICAL GROUP CORPORATION | Director/Board Member | - |
The Kaiteki Institute, Inc.
 The Kaiteki Institute, Inc. Miscellaneous Commercial ServicesCommercial Services The Kaiteki Institute, Inc. engages in the research and investigation of social trends. It also involves in the research and development of new enterprises and operation and management of contract research. The company was founded on April 1, 2009 and is headquartered in Tokyo, Japan. | Director/Board Member | - |
| MITSUBISHI TANABE PHARMA CORPORATION | Chief Executive Officer | 01-04-2014 |
Opleiding van Michihiro Tsuchiya
| Kyoto University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| SUMITOMO ELECTRIC INDUSTRIES, LTD. | Producer Manufacturing |
| MITSUBISHI CHEMICAL GROUP CORPORATION | Process Industries |
| RAQUALIA PHARMA INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Mitsubishi Tanabe Pharma Corp.
 Mitsubishi Tanabe Pharma Corp. Pharmaceuticals: OtherHealth Technology Mitsubishi Tanabe Pharma Corp. engages in the research, development, manufacture, and sale of pharmaceutical products. Its products include Remicade, Ceredist, Talion, Kremezin, Maintate, Simponi, Lexapro, Tenelia, Tetrabik, and Imusera. The company was founded by Gohei Tanabeya in 1678 and is headquartered in Osaka, Japan. | Health Technology |
The Kaiteki Institute, Inc.
The Kaiteki Institute, Inc. Miscellaneous Commercial ServicesCommercial Services The Kaiteki Institute, Inc. engages in the research and investigation of social trends. It also involves in the research and development of new enterprises and operation and management of contract research. The company was founded on April 1, 2009 and is headquartered in Tokyo, Japan. | Commercial Services |
